
Nabriva Therapeutics (NBRV) Latest News & Updates
Explore latest Nabriva Therapeutics (NBRV) News and Updates
Stay updated on Nabriva Therapeutics (NBRV) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Nabriva Therapeutics (NBRV)
Order type
Buy in
Order amount
Est. shares
0 shares
GlobeNewsWire •

Seeking Alpha •

GlobeNewsWire •

GlobeNewsWire •


GlobeNewsWire •


GlobeNewsWire •

GlobeNewsWire •


Zacks Investment Research •


Zacks Investment Research •

Zacks Investment Research •



Nabriva Therapeutics plc (NBRV) CEO Theodore Schroeder on Q3 2021 Results - Earnings Call Transcript
Seeking Alpha •

GlobeNewsWire •


GlobeNewsWire •


Nabriva Publishes Data Demonstrating the Potent Anti-Inflammatory Properties of XENLETA® (lefamulin)
GlobeNewsWire •

GlobeNewsWire •


GlobeNewsWire •
